The financial burden of diabetes and prediabetes treatment costs employers and healthcare systems hundreds of billions of dollars each year, with afflicted employees spending on average $16,500 a year for treatment.
For Omada Health and Dow Chemical, a switch to data-driven digital care treatment programs resulted in significant cost savings and health improvements through their organizations, changing the way prediabetes can be managed via a workplace care benefit.
